TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
8 hedge funds and large institutions have $1.39M invested in TIANYIN PHARMACEUTICAL in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
39% more capital invested
Capital invested by funds: $1M → $1.39M (+$388K)
14% more funds holding
Funds holding: 7 → 8 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
Top Sellers
TPI Hedge Fund Activity: Q4 2014 in Review
8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2014, worth a combined $1.39M — up 39% from $1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TPI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $183K. The largest seller was Pope Asset Management, cutting an estimated $23.1K.
- 8 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2014, up from 7 in Q3 2014.
- Funds reported $1.39M of TIANYIN PHARMACEUTICAL stock for Q4 2014, up 39% quarter-over-quarter.
- 4 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2014 and 2 closed out, a net change of +2 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q4 2014 was California Public Employees Retirement System, an estimated $183K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q4 2014 was Pope Asset Management, an estimated $23.1K sold.
Based on aggregated 13F filings for Q4 2014.